INCLISIRAN for Type iia hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 313 adverse event reports in the FDA FAERS database where INCLISIRAN was used for Type iia hyperlipidaemia.
Most Reported Side Effects for INCLISIRAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Arthralgia | 689 | 10.8% | 2 | 23 |
| Myalgia | 518 | 8.1% | 0 | 14 |
| Injection site pain | 488 | 7.7% | 0 | 20 |
| Low density lipoprotein increased | 423 | 6.7% | 3 | 5 |
| Pain in extremity | 417 | 6.6% | 0 | 34 |
| Pain | 342 | 5.4% | 1 | 27 |
| Fatigue | 325 | 5.1% | 3 | 26 |
| Drug ineffective | 318 | 5.0% | 1 | 17 |
| Diarrhoea | 309 | 4.9% | 1 | 29 |
| Dyspnoea | 297 | 4.7% | 10 | 52 |
| Headache | 234 | 3.7% | 2 | 19 |
| Rash | 207 | 3.3% | 0 | 10 |
| Product storage error | 204 | 3.2% | 0 | 0 |
| Muscle spasms | 202 | 3.2% | 0 | 16 |
| Injection site reaction | 179 | 2.8% | 0 | 2 |
Other Indications for INCLISIRAN
Product used for unknown indication (3,669)
Arteriosclerosis (539)
Hyperlipidaemia (516)
Hypercholesterolaemia (486)
Low density lipoprotein increased (392)
Blood cholesterol increased (161)
Low density lipoprotein decreased (106)
Low density lipoprotein (103)
Dyslipidaemia (94)
Coronary artery disease (60)
Other Drugs Used for Type iia hyperlipidaemia
EVOLOCUMAB (5,556)
LOMITAPIDE (3,314)
ALIROCUMAB (1,913)
ATORVASTATIN (637)
EZETIMIBE (562)
ROSUVASTATIN (547)
SIMVASTATIN (294)
PRAVASTATIN (152)
JUXTAPID (145)
MIPOMERSEN (138)